WOR.AU

12.97

-1.14%↓

WOR.AU

12.97

-1.14%↓

WOR.AU

12.97

-1.14%↓

WOR.AU

12.97

-1.14%↓

WOR.AU

12.97

-1.14%↓

Search

McMillan Shakespeare Ltd

Geschlossen

BrancheIndustrie

17.28 0.29

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

17.03

Max

17.32

Schlüsselkennzahlen

By Trading Economics

Verkäufe

287M

KGV

Branchendurchschnitt

12.482

41.244

Dividendenrendite

8.75

Angestellte

1,311

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+15.07% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

8.75%

2.18%

Nächste Dividendenausschüttung

27. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

225M

1.2B

Vorheriger Eröffnungskurs

16.99

Vorheriger Schlusskurs

17.28

Nachrichtenstimmung

By Acuity

29%

71%

98 / 454 Ranking in Industrials

McMillan Shakespeare Ltd Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Jan. 2026, 23:11 UTC

Ergebnisse

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7. Jan. 2026, 22:55 UTC

Wichtige Markttreiber

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7. Jan. 2026, 21:39 UTC

Wichtige Markttreiber

Raytheon Down Following Trump Post Criticizing Company

7. Jan. 2026, 20:13 UTC

Wichtige Markttreiber

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7. Jan. 2026, 20:03 UTC

Wichtige Markttreiber

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7. Jan. 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7. Jan. 2026, 23:46 UTC

Market Talk

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7. Jan. 2026, 23:42 UTC

Akquisitionen, Fusionen, Übernahmen

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7. Jan. 2026, 23:34 UTC

Market Talk

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7. Jan. 2026, 23:29 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7. Jan. 2026, 22:48 UTC

Market Talk

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7. Jan. 2026, 22:46 UTC

Ergebnisse

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7. Jan. 2026, 22:45 UTC

Ergebnisse

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7. Jan. 2026, 22:43 UTC

Akquisitionen, Fusionen, Übernahmen

Revolution Medicines Draws Takeover Interest -- 2nd Update

7. Jan. 2026, 22:42 UTC

Ergebnisse

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7. Jan. 2026, 22:41 UTC

Ergebnisse

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7. Jan. 2026, 22:41 UTC

Ergebnisse

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7. Jan. 2026, 22:40 UTC

Wichtige Markttreiber

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7. Jan. 2026, 22:31 UTC

Market Talk

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7. Jan. 2026, 22:22 UTC

Market Talk

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7. Jan. 2026, 22:01 UTC

Market Talk

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7. Jan. 2026, 21:46 UTC

Market Talk

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7. Jan. 2026, 21:22 UTC

Akquisitionen, Fusionen, Übernahmen

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7. Jan. 2026, 21:18 UTC

Akquisitionen, Fusionen, Übernahmen

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7. Jan. 2026, 21:05 UTC

Akquisitionen, Fusionen, Übernahmen

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7. Jan. 2026, 20:29 UTC

Akquisitionen, Fusionen, Übernahmen

AbbVie Near Deal for Revolution Medicines -- Update

7. Jan. 2026, 20:27 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7. Jan. 2026, 19:58 UTC

Market Talk

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7. Jan. 2026, 19:48 UTC

Wichtige Markttreiber

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Peer-Vergleich

Kursveränderung

McMillan Shakespeare Ltd Prognose

Kursziel

By TipRanks

15.07% Vorteil

12-Monats-Prognose

Durchschnitt 19.803 AUD  15.07%

Hoch 21.5 AUD

Tief 18.1 AUD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McMillan Shakespeare Ltd – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

1

Buy

1

Halten

0

Sell

Stimmung

By Acuity

98 / 454 Ranking in Industrie

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McMillan Shakespeare Ltd

McMillan Shakespeare Limited provides salary packaging, novated leasing, disability plan management, support co-ordination, asset management, and related financial products and services in Australia and New Zealand. It operates through Group Remuneration Services, Asset Management Services, and Plan and Support Services segments. The Group Remuneration Services segment offers salary packaging and ancillary services, including novated leasing asset and finance procurement, motor vehicle administration, and other services. The Asset Management Services segment provides financing and ancillary management services related with motor vehicles, commercial vehicles, and equipment. The Plan and Support Services segment offers plan management and support coordination services to participants in the national disability insurance scheme. It serves federal and state governments, public and private sectors, and health and charitable organizations. The company founded in 1988 and is headquartered in Melbourne, Australia.
help-icon Live chat